All companies
Visit website
Elemeno Health (YC S16)
OperatingElemeno Health, Inc.
Biotech · Founded 2016
Minority-founded
Empowering staff at the point of care: Improving safety, and fighting COVID
Post-money valuation ⓘ
$6.0M
As of Apr 2025 · from ELEMENO HEALTH Preferred Stock 3 · pre-money + amount raised, not a traded price
Total raised
$2,319,408
Across 3 rounds since 2020
Latest share price
$0.0569
ELEMENO HEALTH Preferred Stock 3 offering price
Financials
FY2018–FY2025 · from SEC filings · hover any figure for its source$231K
−$1.3M
2018
$604K
−$1.1M
2019
$1.0M
−$1.3M
2020
$1.2M
−$3.0M
2021
$1.5M
−$4.0M
2022
$1.7M
−$5.0M
2023
$2.4M
−$2.5M
2024
$2.6M
−$1.4M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$231,233
$603,763
$1,047,195
$1,163,372
$1,515,596
$1,718,775
$2,420,278
$2,623,648
Cost of goods sold
$11,828
$152,673
$334,204
$598,935
$839,123
$1,347,484
$895,621
$658,471
Gross margin
95%
75%
68%
49%
45%
22%
63%
75%
Net income
-$1,308,443
-$1,116,953
-$1,349,246
-$3,022,531
-$4,006,183
-$5,038,549
-$2,537,697
-$1,445,890
Taxes paid
$800
$800
$800
$10,322
$3,363
$4,696
$12,117
$3,206
Balance sheet
Cash
$326,524
$251,677
$1,905,551
$588,759
$3,627,979
$2,900,788
$864,994
$333,284
Accounts receivable
$12,500
$214,142
$156,000
$410,275
$244,140
$226,850
$724,310
$222,322
Total assets
$395,040
$542,441
$2,260,504
$1,067,977
$4,075,376
$3,306,630
$1,781,406
$715,215
Short-term debt
$0
$25,620
$38,743
$33,459
$761,498
$1,716,673
$2,037,778
$1,732,939
Long-term debt
$702,726
$1,509,807
$1,705,225
$35,000
$0
$0
$5,000
$2,500
Total liabilities
$702,726
$1,535,427
$1,743,968
$68,459
$761,498
$1,716,673
$2,042,778
$1,735,439
Other
Headcount
—
12
23
26
—
20
—
18
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$12.0M
Valuation cap
$21.2M
post-money
$6.0M
post-money
Elemeno Health Crowd Safe 1
Elemeno Health Common Stock 1
ELEMENO HEALTH Preferred Stock 3
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised — / $2.5MPost-money $6M
Raised $1.2M / $3.9MInvestors 339Post-money $21.2M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 3 of 6 annual reports (FY2020–FY2025)
4,072 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 23 filings on EDGARSource: ManualCIK 0001805018Share price $0.0569
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.